AURA
Income statement / Annual
Last year (2024), Aura Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Aura Biosciences, Inc.'s net income was -$86.92 M.
See Aura Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$1.30 M
|
$0.00
|
$0.00
|
$0.00
|
$509.00 K
|
| Gross Profit |
$0.00
|
-$1.30 M
|
$0.00
|
$0.00
|
$0.00
|
-$509.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$73.30 M
|
$63.94 M
|
$42.24 M
|
$25.16 M
|
$18.04 M
|
$19.11 M
|
| General & Administrative Expenses |
$22.81 M
|
$19.76 M
|
$18.06 M
|
$10.09 M
|
$4.16 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$22.81 M
|
$19.76 M
|
$18.06 M
|
$10.09 M
|
$4.16 M
|
$4.52 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$96.12 M
|
$83.70 M
|
$60.30 M
|
$35.25 M
|
$22.21 M
|
$23.63 M
|
| Cost And Expenses |
$96.12 M
|
$84.99 M
|
$60.30 M
|
$35.25 M
|
$22.21 M
|
$24.14 M
|
| Interest Income |
$9.43 M
|
$8.59 M
|
$1.86 M
|
$13.00 K
|
$3.00
|
$5.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$13.00 K
|
$3.00 K
|
$5.00 K
|
| Depreciation & Amortization |
$1.22 M
|
$1.30 M
|
$1.18 M
|
$831.00 K
|
$831.00 K
|
$509.00 K
|
| EBITDA |
-$94.89 M |
-$83.70 M |
-$59.12 M |
-$34.42 M |
-$21.38 M |
-$23.69 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$9.31 M
|
$8.72 M
|
$1.53 M
|
-$1.00 K
|
$0.00
|
-$60.00 K
|
| Income Before Tax |
-$86.81 M
|
-$76.27 M
|
-$58.76 M
|
-$35.25 M
|
-$22.21 M
|
-$24.20 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$112.00 K
|
$137.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$86.92 M
|
-$76.41 M
|
-$58.76 M
|
-$35.25 M
|
-$22.21 M
|
-$24.20 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.75 |
-1.93 |
-1.96 |
-1.58 |
-1.03 |
-0.0083 |
| EPS Diluted |
-1.75 |
-1.93 |
-1.96 |
-1.58 |
-1.03 |
-0.0083 |
| Weighted Average Shares Out |
$49.65 M
|
$39.62 M
|
$29.94 M
|
$29.21 M
|
$29.22 M
|
$2.92 B
|
| Weighted Average Shares Out Diluted |
$49.65 M
|
$39.62 M
|
$29.94 M
|
$29.21 M
|
$29.22 M
|
$2.92 B
|
| Link |
|
|
|
|
|
|
